HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Steven P Gygi Selected Research

Cullin 1

3/2011SCF(FBW7) regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction.
9/2010Rictor forms a complex with Cullin-1 to promote SGK1 ubiquitination and destruction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Steven P Gygi Research Topics

Disease

61Neoplasms (Cancer)
02/2022 - 08/2003
12Inflammation (Inflammations)
01/2022 - 07/2012
12Obesity
01/2021 - 08/2009
10Infections
01/2021 - 03/2002
8Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022 - 02/2008
8Insulin Resistance
01/2018 - 01/2010
7Alzheimer Disease (Alzheimer's Disease)
01/2022 - 02/2004
7Breast Neoplasms (Breast Cancer)
01/2021 - 10/2004
7Carcinogenesis
12/2020 - 09/2004
6Fanconi Anemia (Fanconi's Anemia)
01/2020 - 04/2007
6Genomic Instability
01/2018 - 12/2008
5Mitochondrial Diseases (Mitochondrial Disease)
03/2022 - 08/2009
5Neoplasm Metastasis (Metastasis)
10/2017 - 10/2010
5Parkinson Disease (Parkinson's Disease)
11/2014 - 05/2005
4Ovarian Neoplasms (Ovarian Cancer)
12/2021 - 08/2003
4Starvation
11/2021 - 11/2003
4Lung Neoplasms (Lung Cancer)
01/2020 - 12/2007
4Hypoxia (Hypoxemia)
10/2017 - 07/2009
4Type 2 Diabetes Mellitus (MODY)
10/2017 - 01/2013
3Colonic Neoplasms (Colon Cancer)
01/2022 - 03/2011
3Leukemia
01/2021 - 04/2011
3Pancreatic Neoplasms (Pancreatic Cancer)
01/2020 - 12/2016
3Melanoma (Melanoma, Malignant)
01/2020 - 12/2016
3Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2018 - 07/2015
2Multiple Myeloma
03/2022 - 01/2021
2Cognitive Dysfunction
01/2022 - 01/2020
2Acquired Immunodeficiency Syndrome (AIDS)
01/2022 - 04/2009
2Triple Negative Breast Neoplasms
01/2022 - 03/2011
2Cardiomyopathies (Cardiomyopathy)
01/2021 - 03/2014
2Hypertrophy
01/2019 - 11/2014
2Spinal Muscular Atrophy (Progressive Muscular Atrophy)
12/2018 - 01/2018
2Malaria
01/2018 - 05/2015
2Hepatocellular Carcinoma (Hepatoma)
01/2018 - 01/2017
2Cytomegalovirus Infections (Inclusion Disease)
01/2017 - 04/2013
2Tuberculosis (Tuberculoses)
01/2017 - 04/2015
2Adenocarcinoma
01/2017 - 11/2015
2Bardet-Biedl Syndrome (Syndrome, Bardet-Biedl)
11/2014 - 06/2010

Drug/Important Bio-Agent (IBA)

62Proteins (Proteins, Gene)FDA Link
01/2022 - 08/2003
17Phosphotransferases (Kinase)IBA
12/2020 - 12/2007
13Glucose (Dextrose)FDA LinkGeneric
03/2022 - 07/2009
11DNA (Deoxyribonucleic Acid)IBA
01/2022 - 04/2007
10ProteomeIBA
01/2022 - 07/2014
7UbiquitinIBA
11/2016 - 02/2008
6Tyrosine (L-Tyrosine)FDA Link
02/2022 - 12/2007
6Mechanistic Target of Rapamycin Complex 1IBA
11/2021 - 06/2011
5Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
01/2022 - 09/2010
5Proteasome Endopeptidase Complex (Proteasome)IBA
01/2017 - 09/2010
5Amino AcidsFDA Link
01/2017 - 11/2003
5Ligases (Synthetase)IBA
11/2014 - 06/2009
4Peptides (Polypeptides)IBA
02/2022 - 11/2015
4Pharmaceutical PreparationsIBA
02/2022 - 12/2007
4Transcription Factors (Transcription Factor)IBA
01/2021 - 07/2012
4Biological ProductsIBA
12/2020 - 10/2004
4Oncogene Proteins (Oncogene Protein)IBA
01/2020 - 03/2011
4Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2018 - 01/2015
4Glutamine (L-Glutamine)FDA Link
01/2017 - 08/2010
3RNA (Ribonucleic Acid)IBA
01/2022 - 01/2018
3Antiviral Agents (Antivirals)IBA
11/2021 - 01/2020
3Fatty Acids (Saturated Fatty Acids)IBA
12/2020 - 05/2014
3HeterochromatinIBA
01/2020 - 03/2007
3Amyloid beta-PeptidesIBA
01/2020 - 10/2008
3Histones (Histone)IBA
01/2020 - 03/2007
3LigandsIBA
01/2019 - 11/2014
3CyclinsIBA
01/2018 - 06/2011
3EnzymesIBA
01/2018 - 11/2016
3Messenger RNA (mRNA)IBA
10/2017 - 04/2009
3Biomarkers (Surrogate Marker)IBA
01/2016 - 08/2003
3MitogensIBA
01/2015 - 07/2009
3Protein Isoforms (Isoforms)IBA
11/2014 - 09/2004
3Cyclin D1IBA
01/2014 - 01/2010
3IsotopesIBA
04/2011 - 07/2004
3Deubiquitinating EnzymesIBA
10/2010 - 12/2007
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
02/2022 - 01/2021
2InterferonsIBA
01/2022 - 10/2016
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 07/2014
2EpitopesIBA
01/2022 - 09/2017
2Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
01/2022 - 12/2007
2Succinic Acid (Succinate)IBA
01/2021 - 01/2018
2Uncoupling Protein 1IBA
01/2021 - 07/2013
2ChromatinIBA
01/2021 - 01/2020
2CytokinesIBA
01/2021 - 01/2021
2Adenosine Triphosphate (ATP)IBA
01/2020 - 03/2014
2CarbonIBA
01/2020 - 01/2019
2Cyclin-Dependent Kinase 5IBA
01/2020 - 11/2014
2Mechanistic Target of Rapamycin Complex 2IBA
01/2019 - 11/2013
2Viral ProteinsIBA
01/2019 - 06/2014
2Cyclin EIBA
01/2018 - 03/2011
2Mitogen-Activated Protein KinasesIBA
01/2018 - 01/2015
2Small Interfering RNA (siRNA)IBA
01/2018 - 03/2007
2Lysine (L-Lysine)FDA Link
01/2018 - 02/2008
2NicotineFDA Link
01/2018 - 10/2015
2Retinaldehyde (Retinal)IBA
10/2017 - 01/2016
2MTOR InhibitorsIBA
08/2017 - 04/2012
2AdipokinesIBA
11/2015 - 11/2014
2ClathrinIBA
11/2015 - 06/2010
2AdiponectinIBA
11/2015 - 11/2014
2Hormones (Hormone)IBA
11/2015 - 01/2013
2Membrane Proteins (Integral Membrane Proteins)IBA
07/2015 - 06/2010

Therapy/Procedure

17Therapeutics
03/2022 - 12/2007
3Immunotherapy
01/2022 - 01/2019